Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Edmond Differding is active.

Publication


Featured researches published by Edmond Differding.


Letters in Peptide Science | 1995

Bioactive conformations of peptides and mimetics as milestones in drug design: Investigation of NK1 receptor antagonists

Solo Goldstein; Michel Neuwels; Florence Moureau; Didier Berckmans; Marie-Agnes Lassoie; Edmond Differding; Raymond Houssin; Jean-Pierre Hénichart

Nine potent and selective substance P receptor antagonists (NK1 -) were analyzed with respect to their conformational space, with the aim to suggest probable conformations adopted at the receptor site and superposition rules for each structure (pharmacophore mapping). Key atoms within the ligands as well as receptor site points were considered in order to identify acceptable solutions (DISCO program). The results obtained allowed the suggestion or probable peptidic pharmacophores based on the structure of 1 (FK888). This knowledge was used to search commercial databases. The number and diversity of known retrieved NK1 antagonists allowed a general evaluation of the proposed pharmacophores. Moreover, a search in our proprietary database detected a short peptide with modest affinity but high selectivity for the NK1 receptor. The combination of molecular modeling with database searches is useful in a strategy aiming to develop new NK1 antagonists starting from existing knowledge.


Letters in Peptide Science | 1995

Comparative conformational analysis of two endothelin-B antagonists

Solo Goldstein; Michel Neuwels; Patrick Culot; Edmond Differding; Charles Dogimont; Yvo van Assche; Marie-Hélène Brichard; Drina Jaspers; Georges Van Binst; A. Scarso; Jean-Pierre Hénichart

A comparative conformational analysis of two short pseudopeptides with ETB receptor affinity has been performed by molecular modelling and NMR techniques. This analysis aimed to get insight into probable biorelevant conformations and pharmacophoric patterns necessary for an efficient interaction with the receptor. Thus, it was shown that the two compounds can adopt γ-turn (or γ-turn-like) conformations, based on which the synthesis of particular, more rigid analogs might be proposed. The results obtained should prove valuable in a strategy aiming to design new endothelin antagonists following a peptide to non-peptide approach.


Journal of Medicinal Chemistry | 2004

Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity.

Benoit Kenda; Alain Matagne; Patrice Talaga; Patrick Pasau; Edmond Differding; Bénédicte Lallemand; Anne Frycia; Florence Moureau; Henrik Klitgaard; Michel Gillard; Bruno Fuks; Philippe Michel


Archive | 2001

2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses

Edmond Differding; Benoit Kenda; Bénédicte Lallemand; Alain Matagne; Philippe Michel; Patrick Pasau; Patrice Talaga


Archive | 1987

Substituted 1H-imidazoles

Jean-Pierre Geerts; Geneviève Motte; Edmond Differding; Jean-Pierre Henichart


Archive | 1995

Substituted 1H-imidazoles having alpha 2-agonistic and alpha 1-antagonistic activity

Jean-Pierre Geerts; Geneviève Motte; Edmond Differding; Jean-Pierre Henichart


Archive | 2000

Compounds and methods for treatment of asthma, allergy and inflammatory disorders

Ralph Scannell; Pierre Chatelain; Anna Toy-Palmer; Edmond Differding; James L. Ellis; Marie-Agnes Lassoie; Michelle Young; Xiong Cai; Sajjat Hussoin; Gurmit Grewal; Tim Lewis


Archive | 2005

2-oxo-1-pyrrolidine derivative, method for producing the same and use thereof

Edmond Differding; Benoit Kenda; Bénédicte Lallemand; Alain Matagne; Philippe Michel; Patrick Pasau; Patrice Talaga; ケンダ、ベノワ; タラガ、パトリス; ディファーディング、エドモンド; パソー、パトリック; マターニュ、アラン; ミシェル、フィリップ; ラルマン、ベネディクト


Archive | 2001

2-Oxo-1-Pyrrolidinderivate und ihre pharmazeutische Verwendung

Edmond Differding; Benoit Kenda; Bénédicte Lallemand; Alain Matagne; Philippe Michel; Patrick Pasau; Patrice Talaga


Archive | 2001

2-oxo-1-pyrrolidine derivative and its pharmaceutical uses

Edmond Differding; Benoit Kenda; Bénédicte Lallemand; Alain Matagne; Philippe Michel; Patrick Pasau; Patrice Talaga

Researchain Logo
Decentralizing Knowledge